Kailera Therapeutics, Inc. (KLRA)的股价在盘前交易中上涨了1.9%。此前,该公司宣布其研发的一款减肥药物在中国进行的后期临床试验中达到了主要终点。这一积极进展增强了市场对其药物开发前景的信心。
Kailera Therapeutics, Inc. (KLRA)的股价在盘前交易中上涨了1.9%。此前,该公司宣布其研发的一款减肥药物在中国进行的后期临床试验中达到了主要终点。这一积极进展增强了市场对其药物开发前景的信心。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.